期刊文献+

儿童系统性红斑狼疮100例 被引量:9

Clinical Analysis of Systemic Lupus Erythematosus in 100 Children
原文传递
导出
摘要 目的探讨儿童SLE的临床和实验室指标特点及狼疮性肾炎(LN)的肾脏病理类型。方法选取2001年1月-2011年1月本院住院确诊的SLE患儿100例,其中LN 82例,分析其临床表现、实验室和病理检查资料,应用SAS 9.1软件对SLE及各病理类型LN按临床及实验室检查特点行χ2检验。结果 100例SLE患儿,男19例,女81例;发病年龄(10.28±2.98)岁。发病高峰为9~14岁的女性患儿。新生儿1例。临床表现以发热(54%)、皮肤损害(54%)最常见,其次为水肿(34%)、关节炎(22%)、肝脾大(18%)、淋巴结大(15%)、口腔溃疡(4%)。SLE患儿的肾脏累及率为82%。其中肾炎性肾病占33%;血液系统累及率较高,其中贫血59%、低清蛋白血症53%、血小板降低20%;呼吸系统感染40%,肝损害26%,中枢神经受累16%,浆膜炎13%。免疫学检查血清ANA阳性(82%)、补体C4降低(77%)、补体C3降低(70%)、ESR加快(59%)、dsDNA阳性(52%)。48例肾活检病例均有病理异常,病理类型以Ⅳ型最多,占27%;肾脏累及和无肾脏累及组患儿在补体C3降低(P=0.040 9)、抗dsDNA阳性(P=0.023 0)、水肿(P=0.023 6)方面比较差异均有统计学意义。将48例肾活检病例分为增殖性和非增殖性肾炎2组,对Ⅲ、Ⅳ、Ⅴ型+Ⅲ型和Ⅴ型+Ⅳ型(增殖性病变)和Ⅰ、Ⅱ和Ⅴ型(非增殖性病变)进行统计学分析,发现补体C3降低(P=0.042)、抗ANA阳性(P=0.000 6)、ESR加快(P=0.021 9)、贫血(P=0.003 8)差异有统计学意义。结论儿童SLE肾脏、血液系统及呼吸系统累及率最高。补体C3降低、dsDNA阳性和首发表现为水肿的SLE患儿可能更易累及肾脏。肾脏病理表现为增殖性病变的患儿更易发生贫血,补体C3降低、抗ANA阳性、ESR加快提示增殖性病变处于活动期。 Objective To explore the clinical and laboratory data of children with systemic lupus erythematosus(SLE) and histopathological features of lupus nephritis(LN). Methods Patient records between Jan.2001 to Jan.2011 were retrospectively derived from the Children′s Hospital Affiliated to Shanghai Jiaotong University.The clinical and laboratory data of 100 cases of SLE in childhood(of them,82 had LN)were retrospectively analyzed.One-way analysis of chi-square test were employed to compare the differences between the groups.All analyses were performed by using the SAS 9.1 software. Results Of the 100 cases of SLE,19 were male and 81 were female,and the mean age was(10.28 ±2.98) years old.The incidence of female patients between 9 and 14 years was the top,and 1 case was neonate.Most patients showed some clinical manifestation in kidney disease(82%),and nephrosonephritis was the most common clinical feature(33%),most of the patients had class the Ⅳ LN(27%).In these patients,the incidence of fever was 54%,skin lesion was 54%,the others were: edema(34%),arthritis(22%),hepatosplenomega(18%),lymphadenectasis(15%),oral ulcer(4%).Hematologic system cumulative percentage was high,anemia(59%),hypoalbuminema(53%),thrombocytopenia(20%).The respiratory infection(40%) was the most common complication,the others were: hepatic involvement(26%),central nervous system(16%),serositis(13%).Immune indexes:decreased C3 complement(70%),decreased C4 complement(77%),ESR(59%),ANA(82%),dsDNA(52%).While the patients with SLE(non-LN)and LN classes showed significant differences in decreased C3 complement(P=0.040 9),dsDNA(P=0.023 0),edema(P=0.023 6).Forty-eight patients(renal biopsies) were classified into two classes: DPGN(type Ⅲ,Ⅳ,Ⅴ+type Ⅲ,type Ⅴ+type Ⅳ),non-DPGN(type Ⅰ,Ⅱ,Ⅴ).There were significant differences in decreased C3 complement(P=0.041 6),ANA(P=0.000 6),increased ESR(P=0.021 9),anemia(P=0.003 8) between these 2 groups. Conclusions Kidney disease,respiratory system and the blood system are involved as he highest rate in childhood SLE with decreased C3 complement,dsDNA,edema may be more easy to develop LN,and DPGN patients have more chances to produce complications such as anemia.Decreased C3 complement,ANA positive,increased ESR also indicate that DPGN stay active stage in the whole disease progress.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2012年第21期1660-1662,共3页 Journal of Applied Clinical Pediatrics
关键词 系统性红斑狼疮 狼疮性肾炎 儿童 systemic lupus erythematosus lupus nephritis child
  • 相关文献

参考文献17

  • 1范文强,王文翔.系统性红斑狼疮合并病态窦房结综合征2例[J].新乡医学院学报,2010,27(2):160-160. 被引量:8
  • 2中华医学会儿科学分会免疫学组.儿童系统性红斑狼疮诊疗建议[J].屮华儿科杂志,2011,49(7). :506 -514.
  • 3儿童常见肾脏疾病诊治循证指南(试行)(六):狼疮性肾炎诊断治疗指南[J].中华儿科杂志,2010,48(9):687-690. 被引量:41
  • 4Weening JJ,D,agati VD,Schwartz MM,et al. The classification of glo-merulonephritis in systemic lupus erythematosus revisited[ J]. y Am SocNephrol,2004,15(2). :241 -250.
  • 5Chen Y,Chen GL,Zhu CQ,et al. Severe systemic lupus erythematosus inemergency department : A retrospective single - center study from China[J]. Clin Rheumatol,2QU^{JJ). : 1463 - 1469.
  • 6刘婷,赵晓东.系统性红斑狼疮111例患儿临床及病情活动分析[J].实用儿科临床杂志,2010,25(21):1648-1650. 被引量:5
  • 7Lilleby V, Aalokken TM, Johansen B, et al. Pulmonary involvement inpatients with childhood - onset systemic lupus erythematosus [ J]. ClinExp Rheumatol,2006,24(2). : 203 -208.
  • 8Sciascia S,Ceberio L,Garcia - Fernandez C,et al. Systemic lupus ery-thematosus and infections : Clinical importance of conventional and up-coming biomarkers[ J]. Autoimmun Rev,20J2,[ Epub ahead of print].
  • 9Forger F,Matthias T,Oppermann M,et al. Clinical significance of anti -dsDNA antibodies as a prognostic marker for lupus nephritis[ J]. Lupus,2004,13(1). : 36 -44.
  • 10Robak E, Robak T. Novel and emerging drugs for systemic lupus ery-thematosus :Mechanism of action and therapeutic activity [J]. Curr Medaem,2012,19(3). : 438 -453.

二级参考文献43

  • 1安媛,李茹,栗占国.C反应蛋白在鉴别系统性红斑狼疮活动与合并感染中的意义[J].中华风湿病学杂志,2005,9(5):299-302. 被引量:40
  • 2王禹,刘晓丹,栗霄立,王力宁,周希静.亚临床狼疮肾炎的临床病理分析及随访[J].中华肾脏病杂志,2006,22(6):370-371. 被引量:4
  • 3Austin HA,Muenz LR,Joyce KM,et al.Prognosic factors in lupus nephritis.Contribution of renal histologic data.Am J Med,1983,75:382-391.
  • 4Esdaile JM JL,MacKenzie T,Kashgarian M,et al.The benefit of early treatment with immunosuppressive agents in lupus nephritis.J Rheumatol,1994,21:2046-2051.
  • 5Houssiau FA VC,D'Cruz D,Sebastiani GD,et al.Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis:lessons from long-term followup of patients in the EuroLupus Nephritis Trial.Arthritis Rheum,2004,50:3934-3940.
  • 6Sauter M,Anders HJ.Lupus nephritis.Minerva Med,2007,98:749-758.
  • 7Flanc RS,Roberts MA,Strippoli GF,et al.Treatment of diffuse proliferative lupus nephritis:a meta-analysis of randomized controlled trials.Am J Kidney Dis,2004,43:197-208.
  • 8Grootscholten CLG,Hagen EC,van den Wall Bake AW,et al.Dutch working party on systemic lupus erythematosus.Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis.A randomized controlled trial.Kidney Iht,2006,70:732-742.
  • 9Bertsias G,Ioannidis JP,Boletis J,et al.EULAR recommendations for the management of systemic lupus erythematosus.Report of a task force of the EULAR standing committee for international clinical studies including therapeutics.Ann Rheum Dis,2008,67:195-205.
  • 10Chan TM,Tse KC,Tang CS,et al.Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.J Am Soc Nephrol,2005,16:1076-1084.

共引文献50

同被引文献96

  • 1仲人前,耿红莲.自身免疫性疾病实验室诊断进展[J].中华检验医学杂志,2005,28(8):867-869. 被引量:32
  • 2金秀娟,沈鹰.儿童系统性红斑狼疮41例临床特点分析[J].医学临床研究,2006,23(12):1960-1961. 被引量:1
  • 3Wallaee DJ, Haha BH. Lupus erythematosus [ M] .5th ed. Baltimore: Williams, 1997 : 627 -633,.
  • 4Amaral B, Murphy G, Ioannou Y, et al. A comparison of the outcome of adolescent and adult- onset systemic lupus erythematosus [ J ]. Rheumatology (Oxford), 2014, 53 (6): 1130-1135.
  • 5Wang DG, Hao L, Pan HF, et al. New evidence for roles of antinucleosoml antibodies in systemic lupus erythematosus [ J ]. Clin Rbeumatol, 2012, 31 (2) 399-400.
  • 6韩玉昆,陈树宝,杨锡强,等.小儿系统性红斑狼疮[M].合肥:安徽科学技术出版社,2000:72.
  • 7陈景珠,林果为,王吉耀.实用内科学[M].北京:人民卫生出版社,2003:2600-2610.
  • 8Wang DG, Hao L, Pan HF, et al. New evidence for roles of antinucleosome antibodies in systemic lupus erythematosus [ J ]. Clin Rheumatol, 2012, 31 (2): 399-400.
  • 9Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus [ J] .N Engl J Med, 2003, 349 (16): 1526 - 1533.
  • 10Feki S, Frikha F, Ben Hadj Hmida Y, et al. Prevalence and diagnostic value of antibodies without identified antigentic target: a retrospective study of 90 patients [J]. Rev Med Interne, 2012, 33 (9) : 475 -481.

引证文献9

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部